高组织嗜酸性粒细胞增多作为预测嗜酸性慢性鼻窦炎复发的标志物:系统评价与荟萃分析
该系统评价与荟萃分析纳入11项研究共3183例术后嗜酸性慢性鼻窦炎(ECRS)患者,评估组织嗜酸性粒细胞计数(eos/HPF)预测复发以定义ECRS的诊断准确性。以复发风险为主要结局,>55 eos/HPF阈值显示最高灵敏度0.87、特异度0.97及诊断比值比232.7,推荐用于预测ECRS复发可能性。
要点
- >55 eos/HPF预测ECRS复发灵敏度0.87、特异度0.97。
- 诊断比值比232.7(95%CI 91.0-595.1)支持该阈值。
- 研究质量、地域、随访及设计不影响诊断准确性。
核心结论
- 组织嗜酸性粒细胞计数具有良好诊断准确性,可用于识别ECRS患者并预测术后复发风险。
- 基于荟萃分析结果,推荐>55 eos/HPF作为预测ECRS复发可能性的阈值。
研究设计与样本
- 系统评价与荟萃分析,检索Embase、Medline和PubMed数据库中报告ECRS术后高组织嗜酸性粒细胞增多(HTE)与复发的研究。
- 纳入11篇文章,共3183例患者,采用随机效应双变量荟萃分析计算不同HTE截断值的汇总灵敏度、特异度及诊断比值比。
主要发现
- >55 eos/HPF截断值显示最高灵敏度0.87(95%CI 0.82-0.91)、特异度0.97(95%CI 0.93-0.99)及诊断比值比232.7(95%CI 91.0-595.1)。
- 荟萃回归分析显示研究质量评估(p=0.1287)、地理位置(p=0.3745)、随访时间(p=0.2879)和研究设计(p=0.1865)均不影响测试准确性。
关键数值与推荐
- 推荐>55 eos/HPF作为预测ECRS复发可能性的截断值。
- 该阈值下灵敏度0.87(95%CI 0.82-0.91)、特异度0.97(95%CI 0.93-0.99)、诊断比值比232.7(95%CI 91.0-595.1)。
临床怎么用
- 术后病理组织嗜酸性粒细胞计数>55 eos/HPF可辅助识别ECRS复发高风险患者并指导随访强度。
- 该阈值可作为ECRS诊断标准制定的参考依据,但需结合临床综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with eosinophilic chronic rhinosinusitis (ECRS) have been shown to have greater disease severity and poorer treatment outcomes after sinus surgery. Although the inflammatory pattern of ECRS is essential to diagnosing this subtype, there is currently no consensus for diagnosis. Our aim in this study was to determine whether high tissue eosinophilia (HTE), measured as eosinophils per high-power field (eos/HPF), could be used to define ECRS based on likelihood of recurrence. METHODS: Embase, Medline, and PubMed databases were searched for studies that reported HTE and recurrence in ECRS patients after surgical treatment. We used a random-effects bivariate meta-analysis to calculate summary sensitivity, specificity, and diagnostic odds ratios (DORs) for detecting ECRS at different HTE cut-off scores using risk of recurrence as the primary outcome. RESULTS: We identified 11 articles (n = 3183) that reported HTE associated with recurrence. A cut-off value of >55 eos/HPF showed the highest sensitivity (0.87; 95% confidence interval [CI], 0.82-0.91), specificity (0.97; 95% CI, 0.93-0.99), and DOR (232.7; 95% CI, 91.0-595.1). Meta-regression analysis performed showed that the Quality Assessment of Diagnostic Accuracy Studies score (p = 0.1287), geographic location (p = 0.3745), follow-up time (p = 0.2879), and study design (p = 0.1865) did not affect the test accuracy. CONCLUSION: Our findings suggest that using eos/HPF has good diagnostic accuracy and may be a useful tool for identifying ECRS patients. Based on the results of our meta-analysis, we recommend a cut-off value of >55 eos/HPF for predicting the likelihood of recurrence of ECRS.
引用
- McHugh T, Snidvongs K, Xie M, et al. High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018. PMID: 30091850. doi:10.1002/alr.22194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。